Bickell Nina A, Cohen Alicia
Department of Health Policy, Mount Sinai School of Medicine, New York, NY 10029, USA.
Mt Sinai J Med. 2008 Jan-Feb;75(1):23-30. doi: 10.1002/msj.20013.
Effective adjuvant treatments proven to prolong survival for breast cancer exist, yet many women, particularly minority women, do not receive them. Little work has focused on improving the quality of, and reducing racial disparities in, cancer treatment. We describe the application of a conceptual model to direct, design, and implement trials to reduce underuse of effective adjuvant breast cancer treatments.
Content analysis of extensive interviews and focus groups was used to construct a framework of patient, physician, and system-level reasons for underuse. Use of the model then directed development of targeted interventions aimed at ameliorating underlying causes.
The process of identifying patient, physician, and system-level reasons for underuse involved patients, surgeons, surgeon's office staff, and providers of patient assistance. Engaging these individuals both informed the design of our multi-focused interventions and generated interest in trial participation. All 38 surgeons in six unaffiliated institutions and all 25 patient assistance programs approached agreed to participate in the intervention trials.
Identifying reasons for underuse by interviewing patients, physicians, physician office staff, and allied care providers about episodes in which needed care failed to occur helps engage key individuals, and can inform the design and implementation of interventions targeting barriers to delivering high quality breast cancer care to all.
虽然已证实有效的辅助治疗可延长乳腺癌患者的生存期,但许多女性,尤其是少数族裔女性并未接受此类治疗。很少有工作致力于提高癌症治疗的质量并减少种族差异。我们描述了一种概念模型的应用,该模型用于指导、设计和实施试验,以减少有效辅助性乳腺癌治疗的使用不足情况。
通过对广泛的访谈和焦点小组进行内容分析,构建了一个关于使用不足的患者、医生和系统层面原因的框架。然后,使用该模型指导旨在改善潜在原因的针对性干预措施的制定。
确定患者、医生和系统层面使用不足原因的过程涉及患者、外科医生、外科医生办公室工作人员以及患者援助提供者。让这些人参与其中既为我们多方面的干预措施设计提供了信息,也激发了他们参与试验的兴趣。六个非附属机构的所有38名外科医生以及所有25个接触到的患者援助项目均同意参与干预试验。
通过就未提供所需治疗的情况询问患者、医生、医生办公室工作人员和相关护理提供者来确定使用不足的原因,有助于让关键人员参与进来,并可为针对向所有人提供高质量乳腺癌护理的障碍所设计和实施的干预措施提供信息。